Uncategorized
What 7 Analyst Ratings Have To Say About Antero Resources
Latest Ratings for AR Date Firm Action From To Feb 2022 Raymond James Maintains Strong Buy Jan 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Goldman Sachs Upgrades Neutral Buy View More Analyst Ratings for AR View the Latest Analyst Ratings read more
Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews
Latest Ratings for ARCT Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 Raymond James Upgrades Underperform Market Perform Nov 2021 Barclays Maintains Underweight View More Analyst Ratings for ARCT View the Latest Analyst Ratings read more
Anthony Scaramucci Says Bitcoin Is Evolving From A Tech Asset To Digital Gold
Anthony Scaramucci believes Bitcoin (CRYPTO: BTC) is in the midst of a structural transformation, from a volatile tech-aligned investment to a maturing global asset more comparable read more
Oculus Founder Palmer Luckey Reveals He’s In An Invite-Only Group Chat With Just One Entry Rule
Palmer Luckey sold Oculus to Facebook for $2 billion in 2014 and joined an ultra-exclusive group chat for founders who have sold a company for at least $1 billion. read more
Elon Musk, Jeff Bezos, Mark Zuckerberg Gain Billions As US-China Tariff Truce Boosts Tech Billionaires’ Fortunes
The recent relaxation of tariffs between the U.S. and China has sparked a significant market rally, with tech CEOs and founders reaping substantial benefits. read more
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
Alzamend Neuro starts Phase 2 trial of AL001 with novel coil tech to test improved lithium delivery in the brain for multiple mental health conditions. read more
